Calreticulin as an Adjuvant In Vivo to Promote Dendritic Cell Maturation and Enhance Antigen-Specific T Lymphocyte Responses against Melanoma
An endoplasmic reticulum resident protein, calreticulin (CRT), participates in many cellular processes. CRT is a tumor-associated antigen with an important role in antitumor immunity. Previously, we reported that the recombinant CRT fragment 39-272 (CRT/39-272) exhibited superior immunobiological ac...
Saved in:
Main Authors: | Zheng Gong, Ming Chen, Jie Miao, Chao-Jie Han, Qiao Zhong, Fang-Yuan Gong, Xiao-Ming Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/8802004 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Membrane Bound CRT Fragment Accelerates Tumor Growth of Melanoma B16 Cell In Vivo through Promoting M2 Polarization via TLR4
by: Hong-Min Wang, et al.
Published: (2022-01-01) -
Saponin-based adjuvant uptake and induction of antigen cross-presentation by CD11b+ dendritic cells and macrophages
by: Lisa GM Huis in ’t Veld, et al.
Published: (2025-01-01) -
Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic Cells
by: Stefanie Hoyer, et al.
Published: (2015-01-01) -
Efficient genome editing in dicot plants using calreticulin promoter-driven CRISPR/Cas system
by: Bingjie Li, et al.
Published: (2025-02-01) -
CD133 Antigen as a Potential Marker of Melanoma Stem Cells: In Vitro and In Vivo Studies
by: Tomasz Kloskowski, et al.
Published: (2020-01-01)